4 competitive national public projects: ISCIII and MICINN
1 led private project
6 clinical studies
8 publications
FI: 119.10
Publications in Q1: 4 (50%)
Publications in D1: 4 (50%)
Project reviewer for national associations: 1 PI
Member of editorial boards: 1 PI
Milestones
Launch of the project "Cardiac Dysfunction, Cardiovascular Risk, and Genomic Study in Long-Term Survivors of Childhood Cancer (SLPCI)," funded by the Alonso Family Foundation. Principal Investigator: Dr. María Jesús del Cerro.
50% enrollment achieved in the independent clinical trial with cell therapy (ICI19/00092): Phase I/b-III clinical trial to evaluate the efficacy of MSCs in preterm infants as a preventive strategy to reduce the incidence and severity of bronchopulmonary dysplasia - EC 310/22 - PULMESCELL-2
European Clinical Guideline: Van Wegberg AMJ, MacDonald A, Ahring K, Belanger-Quintana A, Beblo S, Blau N, Bosch AM, Burlina A, Campistol J, Coşkun T, Feillet F, Giżewska M, Huijbregts SC, Leuzzi V, Maillot F, Muntau AC, Rocha JC, Romani C, Trefz F, van Spronsen FJ. European Guidelines on the Diagnosis and Treatment of Phenylketonuria: First Revision. Mol Genet Metab. 2025;145(2):109125. doi: 10.1016/j.ymgme.2025.109125.: 40378670.
Launch of a privately funded clinical trial: An Open-label Long-term Follow-up Study to Evaluate the Effects of Sotatercept When Added to Background Pulmonary Arterial Hypertension (PAH) Therapy for the Treatment of PAH (sponsor: MERCK SHARP & DOHME LLC). PI: Dr. María Jesús del Cerro.
Téllez L, Donate J, Guerrero A, Beraza IA, San Martín D, Alvarado E, Echevarría V, Puente Á, Zamora J, Prado SD, Tenes A, Balagué G, Vidal B, Geli C, Rodríguez MÁ, Baiges A, Brujats A, López D, Fernández S, Fortea JI, del Cerro M Jesús, Villanueva C, García JC, Giráldez Á, Albillos A. Early portopulmonary hypertension predicts mortality in patients with cirrhosis: Insights from the
PORTO-DETECT cohort. J. Hepatol. 2025;84(2): 284-292. DOI:10.1016/j.jhep.2025.09.011.
